IRIS - Res&Arch Institutional Research Information System - Research & Archive

IRACI, NUNZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.684
EU - Europa 1.919
AS - Asia 1.878
SA - Sud America 358
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 6.892
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.624
SG - Singapore 716
UA - Ucraina 362
VN - Vietnam 320
IE - Irlanda 291
BR - Brasile 288
CN - Cina 276
RU - Federazione Russa 254
HK - Hong Kong 248
SE - Svezia 235
IT - Italia 217
GB - Regno Unito 125
DE - Germania 108
FI - Finlandia 101
FR - Francia 89
KR - Corea 66
TR - Turchia 63
IN - India 37
BE - Belgio 35
BD - Bangladesh 31
AR - Argentina 29
CA - Canada 21
MX - Messico 20
PL - Polonia 19
IQ - Iraq 18
UZ - Uzbekistan 18
AT - Austria 15
NL - Olanda 15
EC - Ecuador 14
ZA - Sudafrica 14
JP - Giappone 13
SA - Arabia Saudita 12
CH - Svizzera 11
ES - Italia 11
PK - Pakistan 10
CO - Colombia 9
ID - Indonesia 8
PH - Filippine 8
TN - Tunisia 7
JO - Giordania 6
MA - Marocco 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
EG - Egitto 5
PY - Paraguay 5
VE - Venezuela 5
AL - Albania 4
CI - Costa d'Avorio 4
EU - Europa 4
NI - Nicaragua 4
NP - Nepal 4
PA - Panama 4
DO - Repubblica Dominicana 3
JM - Giamaica 3
KE - Kenya 3
AM - Armenia 2
AZ - Azerbaigian 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
GD - Grenada 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
LV - Lettonia 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.892
Salva come PNG Salva come JPEG
Città #
Singapore 507
Chandler 349
Dublin 289
Hong Kong 242
Dong Ket 211
San Jose 191
Jacksonville 190
San Mateo 180
Ashburn 155
Perugia 105
Boardman 98
Santa Clara 93
Moscow 92
Medford 77
Princeton 76
Beijing 67
Seoul 66
Andover 65
Fremont 64
Lauterbourg 64
The Dalles 62
Wilmington 54
Dearborn 52
Ann Arbor 48
Izmir 41
Ho Chi Minh City 39
São Paulo 39
Altamura 35
Brussels 34
Los Angeles 33
Lawrence 30
Piscataway 30
Hanoi 27
New York 26
Norwalk 23
Saint Petersburg 23
Helsinki 20
West Jordan 20
Orem 17
Des Moines 15
Munich 14
Warsaw 14
Hefei 13
San Giustino 13
Tokyo 13
Dallas 12
Brooklyn 11
Philadelphia 11
Atlanta 10
Redmond 10
Falls Church 9
Houston 9
Johannesburg 9
Nanjing 9
Tashkent 9
Brasília 8
Buffalo 8
Chennai 8
London 8
Manchester 8
Shanghai 8
Stockholm 8
Auburn Hills 7
Chicago 7
Montreal 7
Phoenix 7
Recife 7
Rio de Janeiro 7
Rome 7
Simi Valley 7
Amsterdam 6
Belo Horizonte 6
Denver 6
Poplar 6
Redwood City 6
San Diego 6
San Francisco 6
Toronto 6
Tunis 6
Zhengzhou 6
Amman 5
Ankara 5
Buenos Aires 5
Charlotte 5
Columbus 5
Den Haag 5
Guangzhou 5
Istanbul 5
Jeddah 5
Jinan 5
Lappeenranta 5
Salvador 5
San Paolo di Civitate 5
Spoleto 5
Teresina 5
Turku 5
Vienna 5
Woodbridge 5
Abidjan 4
Asunción 4
Totale 4.285
Salva come PNG Salva come JPEG
Nome #
1,3-DIIDRO-BENZIMIDAZOLONI ANALOGHI: PROGETTAZIONE, SINTESI E SAR DI NUOVI INIBITORI NON-NUCLEOSIDICI DELL’RT 329
1,3-Diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 319
beta-CYCLODEXTRIN HINDERS PLGA PLASTICIZATION DURING MICROPARTICLE MANUFACTURING 187
Prion protein ligands as therapeutic agents for neurodegenerative disorders 144
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 132
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 132
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 132
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 123
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 116
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 116
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors 112
Diselenides and benzisoselenazolones as antiproliferative agents and glutathione-S-transferase inhibitors 110
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 110
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 109
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 109
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 108
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 107
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 107
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 106
Binding Mode Prediction of Strand Transfer HIV-1 Integrase Inhibitors Using Tn5 Transposase as a Plausible Surrogate Model for HIV-1 Integrase 105
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 104
Design and synthesis of NR2B Subtype-Selective Antagonist 103
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model. 102
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 102
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 96
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 94
DECODING THE FUNCTION OF THE N-TERMINAL TAIL OF THE CELLULAR PRION PROTEIN TO INSPIRE NOVEL THERAPEUTIC AVENUES FOR NEURODEGENERATIVE DISEASES 94
Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non–Nucleoside reverse Transcriptase Inhibitors 93
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 93
Nuovi antagonisti non-competitivi del recettore NMDA/NR2B:design and sintesi 92
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 92
Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors. 91
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 91
Exploration of the binding mode of HIV-1 integrase strand transfer inhibitors through different computational approaches. 85
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 82
Improvement of water solubility of non-competitive AMPA receptor antagonists by complexation with beta-cyclodextrin. 81
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 81
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands 81
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series. 81
Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 81
Nuovi chemotipi di inibitori dell'HCV NS5B polimerasi 80
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 79
TARGETING CDKs TO INHIBIT THE HIV-1 TAT-MEDIATED TRANSCRIPTION 78
Re-evolution of the 2-phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance 78
Sviluppo di modello farmacoforico predittivo per gli NR2B antagonisti del recettore NMDA 76
Identificazione di Nuovi Inibitori Non-Nucleosidici della Trascrittasi Inversa dell’ HIV-1 Mediante Tecniche di Virtual screening. 75
Designed Multiple Ligands (DLMs) as innovative anti-HIV agents 74
Nuovo modello farmacoforico per inibitori dell’Integrasi dell’HIV-1: ottimizzazione della potenza di composti a struttura 1H-benzilindolica 73
Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors. ChemMedChem 72
New chemotypes to fight HCV infection: discovery of selective inhibitors of HCV replication with pyrazolobenzothiazine scaffold 71
Tn5 Transposase as a useful platform to simulate HIV-1 Integrase inhibitor binding mode 71
Structure-Based Discovery of Pyrazolobenzothiazine Derivatives As Inhibitors of Hepatitis C Virus Replication 70
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 69
Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors. 69
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 68
Targeting the HIV Tat-mediated transcriptional machinery: P-TEFb complex inhibitors 67
HIV-1-IN Strand-Transfer Inhibitors: phenyl ring exploration and synthesis of 1H-benzylindole derivative through fluorine substitutions 66
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 66
The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors 66
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors. 66
Docking studies on a new HIV integrase–Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 66
Pyrazolo[4,3-c][1,2]benzothiazines 5,5-Dioxide: A Promising New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors 65
Pharmacological agents targeting the cellular prion protein 65
INTEGRASE STRAND TRANSFER INHIBITORS (INSTIs): SYNTHESIS AND ANTIVIRAL EFFETCS OF CHLORO-FLUORO SUBSTITUTIONS 64
Studi Computazionali per l’Identificazione di Nuovi Inibitori Non-Nucleosidici della Trascrittasi Inversa dell’HIV- 64
Rational design, synthesis and SAR of 1,3-dihydro- benzimidazolone analogues as new anti-HIV agents 64
Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy. 64
From Small to Powerful: The Fragments Universe and its "Chem-Appeal" 61
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 58
NCp7: targeting a multitasking protein for next-generation anti-HIV drug development part 1: covalent inhibitors 58
NCp7: Targeting a multitask protein for next-generation anti-HIV drug development part 2. Noncovalent inhibitors and nucleic acid binders 57
Progettazione, sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 55
Pharmacophore Modeling, Docking Experiments And Discovery Of New HIV-1 NNRTIs. 55
Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. 54
Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. 53
Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents. 53
L-arginine improves solubility and anti sars-cov-2 mpro activity of rutin but not the antiviral activity in cells 47
Sperm insulin-like growth factor 2 protein levels: implications for early embryo development 9
Totale 7.078
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021223 0 0 0 0 0 0 0 0 0 0 0 223
2021/2022708 16 135 12 37 47 7 5 231 27 15 88 88
2022/2023989 82 141 15 91 82 109 0 56 356 2 33 22
2023/2024481 36 62 23 11 5 8 73 35 63 29 68 68
2024/2025984 2 104 27 107 99 12 76 25 197 98 159 78
2025/20262.083 160 177 106 303 228 195 307 102 231 192 68 14
Totale 7.078